Cargando…

Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells

The observation that depletion or inhibition of regulatory T cells (Tregs) unleashes efficient antitumor effector immune responses that can lead to tumor eradication in mice has opened new perspectives for the development of cancer immunotherapy. The quality and overall efficiency of the effector im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergot, A-S, Durgeau, A, Levacher, B, Colombo, B M, Cohen, J L, Klatzmann, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924606/ https://www.ncbi.nlm.nih.gov/pubmed/20467452 http://dx.doi.org/10.1038/cgt.2010.21

Ejemplares similares

Self-antigen–specific CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
por: Rizzuto, Gabrielle A., et al.
Publicado: (2009)

An Efficient Method for Generating Poxvirus Recombinants in the Absence of Selection
por: Rice, Amanda D., et al.
Publicado: (2011)

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2018)

Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response
por: Guo, Chunqing, et al.
Publicado: (2011)

Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T Cells
por: Ritvo, Paul-Gydéon, et al.
Publicado: (2019)

Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
por: Leddon, Jennifer L, et al.
Publicado: (2015)

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
por: Shrestha, Bishwas, et al.
Publicado: (2020)

Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
por: Durgeau, Aurélie, et al.
Publicado: (2018)

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
por: Durgeau, Aurélie, et al.
Publicado: (2018)

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses
por: Yang, Danlin, et al.
Publicado: (2016)

Absence of central tolerance in Aire-deficient mice synergizes with immune-checkpoint inhibition to enhance antitumor responses
por: Benitez, Asiel A., et al.
Publicado: (2020)

Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
por: Lee, Sung Yong, et al.
Publicado: (2019)

Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity
por: Kochin, Vitaly, et al.
Publicado: (2019)

Regulatory Elements in Vectors for Efficient Generation of Cell Lines Producing Target Proteins
por: Maksimenko, O., et al.
Publicado: (2015)

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
por: Hirschhorn-Cymerman, Daniel, et al.
Publicado: (2009)

Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer
por: Brusko, Todd M., et al.
Publicado: (2010)

Regulatory T Cells As Supporters of Psychoimmune Resilience: Toward Immunotherapy of Major Depressive Disorder
por: Ellul, Pierre, et al.
Publicado: (2018)

Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
por: Silverio, Kimberly A., et al.
Publicado: (2017)

Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice
por: Abadie, Valérie, et al.
Publicado: (2009)

Functional Reprogramming of Regulatory T cells in the absence of Foxp3
por: Charbonnier, Louis-Marie, et al.
Publicado: (2019)

T cell memory is short-lived in the absence of antigen
Publicado: (1991)

Regulatory T-Cells in Pregnancy: Historical Perspective, State of the Art, and Burning Questions
por: Ruocco, Maria Grazia, et al.
Publicado: (2014)

Cancer Cell Membrane Biomimetic Mesoporous Nanozyme System with Efficient ROS Generation for Antitumor Chemoresistance
por: Tang, Wenxue, et al.
Publicado: (2022)

Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus
por: Lin, Jiqiang, et al.
Publicado: (2016)

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
por: Liu, Wenhui, et al.
Publicado: (2021)

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
por: Mashima, Hiroaki, et al.
Publicado: (2020)

Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells
por: Yang, Liu, et al.
Publicado: (2021)

Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
por: Efimova, Iuliia, et al.
Publicado: (2020)

How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?
por: Janelle, Valérie, et al.
Publicado: (2014)

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
por: Yan, Yuheng, et al.
Publicado: (2022)

Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity
por: Kalim, Khalid W, et al.
Publicado: (2022)

Absence of “Original Antigenic Sin” in Autoimmunity Provides an Unforeseen Platform for Immune Therapy
por: Steinman, Lawrence
Publicado: (1999)

Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
por: Jeon, Insu, et al.
Publicado: (2020)

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
por: Moatti, Audrey, et al.
Publicado: (2022)

Efficient isolation of rare B cells using next-generation antigen barcoding
por: Hurtado, Jonathan, et al.
Publicado: (2023)

Innovations in structure-based antigen design and immune monitoring for next generation vaccines
por: Ward, Andrew B, et al.
Publicado: (2020)

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
por: Butterfield, Lisa H., et al.
Publicado: (2019)

Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells
por: Lapierre, Pascal, et al.
Publicado: (2015)

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
por: Dhodapkar, Kavita M., et al.
Publicado: (2002)

Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation
por: Ko, Eric C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_404kah14i9mq7109tn3hlo131j